CircSMAD3 represses VSMC phenotype switching and neointima formation via promoting hnRNPA1 ubiquitination degradation

Shuai Mei,Xiaozhu Ma,Li Zhou,Qidamugai Wuyun,Ziyang Cai,Jiangtao Yan,Hu Ding

DOI: https://doi.org/10.1111/cpr.13742

IF: 8.755

2024-09-03

Cell Proliferation

Abstract:Briefly, circSMAD3 recruits hnRNPA1 to enhance the interaction of hnRNPA1 with WDR76, promote its ubiquitination degradation, facilitate p53 pre‐RNA splicing to activate the p53γ signalling pathway, and eventually maintain the vascular homeostasis. In vascular injury, the downregulated circSMAD3 promotes hnRNPA1 function, deactivates p53γ signalling pathway, and leads to neointima formation. Circular RNAs (circRNAs) are novel regulatory RNAs with high evolutionary conservation and stability, which makes them effective therapeutic agents for various vascular diseases. The SMAD family is a downstream mediator of the canonical transforming growth factor beta (TGF‐β) signalling pathway and has been considered as a critical regulator in vascular injury. However, the role of circRNAs derived from the SMAD family members in vascular physiology remains unclear. In this study, we initially identified potential functional circRNAs originating from the SMAD family using integrated transcriptome screening. circSMAD3, derived from the SMAD3 gene, was identified to be significantly downregulated in vascular injury and atherosclerosis. Transcriptome analysis was conducted to comprehensively illustrate the pathways modulated by circRNAs. Functionally, circSMAD3 repressed vascular smooth muscle cell (VSMC) proliferation and phenotype switching in vitro evidenced by morphological assays, and ameliorated arterial injury‐induced neointima formation in vivo. Mechanistically, circSMAD3 interacted with heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) within the nucleus, enhanced its interaction with E3 ligase WD repeat domain 76 to promote hnRNPA1 ubiquitination degradation, facilitated p53 pre‐RNA splicing, activated the p53γ signalling pathway, and finally suppressed VSMC proliferation and phenotype switching. Our study identifies circSMAD3 as a novel epigenetic regulator that suppresses VSMC proliferation and phenotype switching, thereby attenuating vascular remodelling and providing a new circRNA‐based therapeutic strategy for cardiovascular diseases.

cell biology